Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Checkpointremmer-geïnduceerde inflammatoire artritis ook na stoppen immuuntherapie
apr 2020 | Artritis, Dermato-oncologie, Immuuntherapie, Longoncologie